Theravance Inc (THRX)

10.03
0.16 1.57
NASDAQ : Health Care
Prev Close 10.19
Open 10.15
Day Low/High 10.01 / 10.29
52 Wk Low/High 6.36 / 16.81
Volume 815.56K
Avg Volume 868.80K
Exchange NASDAQ
Shares Outstanding 117.43M
Market Cap 1.15B
EPS -1.50
P/E Ratio N/A
Div & Yield 1.00 (10.20%)
3 Stocks Pushing The Drugs Industry Higher

3 Stocks Pushing The Drugs Industry Higher

TheStreet Ratings group highlights 3 stocks pushing the drugs industry higher today.

5 Stocks Poised to Pop on Bullish Earnings

5 Stocks Poised to Pop on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Mega-Hedge Fund Manager Seth Klarman's Five Best Stock Picks

Klarman's hedge funds' top small-cap picks generate significant alpha.

Insiders Trading THRX KSS TUES ELGX

Insiders Trading THRX KSS TUES ELGX

The top 10 open-market insider purchases and sales filed at the SEC Monday.

GSK And Theravance Announce FDA Acceptance Of FF/VI New Drug Application (NDA) Submission In The US For COPD

GSK And Theravance Announce FDA Acceptance Of FF/VI New Drug Application (NDA) Submission In The US For COPD

Japanese New Drug Application (JNDA) Submitted for COPD and Asthma

Theravance's Management Presents At INC At Morgan Stanley Healthcare Conference (Transcript)

Theravance's Management Presents At INC At Morgan Stanley Healthcare Conference (Transcript)

Theravance's Management Presents at INC at Morgan Stanley Healthcare Conference (Transcript)

GSK And Theravance Announce Completion Of The Phase III Programme For Once-Daily LAMA/LABA (UMEC/VI) In COPD

GSK And Theravance Announce Completion Of The Phase III Programme For Once-Daily LAMA/LABA (UMEC/VI) In COPD

GSK Confirms Its Intention to Commence Global Filings From the End of 2012

Theravance Inc. Stock Downgraded (THRX)

Theravance Inc. Stock Downgraded (THRX)

Theravance (Nasdaq:THRX) has been downgraded by TheStreet Ratings from from a hold to sell.

Theravance, Inc. CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript

Theravance, Inc. CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript

Theravance, Inc. CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript

5 Stocks Poised to Pop on Bullish Earnings

5 Stocks Poised to Pop on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

8 Stocks Soaring on High Volume

8 Stocks Soaring on High Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

8 Stocks Ripping Higher on Big Volume

8 Stocks Ripping Higher on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Theravance Inc. Stock Upgraded (THRX)

Theravance Inc. Stock Upgraded (THRX)

Theravance (Nasdaq:THRX) has been upgraded by TheStreet Ratings from a sell to hold.

No Side Has Control

The buy-sell alternation we've suffered through this expiration week reflects a conflicted market environment.

8 Stocks Rising on Monster Volume

8 Stocks Rising on Monster Volume

nusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

GlaxoSmithKline Boosts Stake in Theravance

GlaxoSmithKline Boosts Stake in Theravance

The drug company will now own more than a 25% stake in Theravance.

Monday's Top 10 Articles, Videos on TheStreet

Monday's Top 10 Articles, Videos on TheStreet

These stories made today's top 10 list of articles and videos on TheStreet.

Theravance Stock Gaps Down On Today's Open (THRX)

Theravance Stock Gaps Down On Today's Open (THRX)

Shares of Theravance (Nasdaq:THRX) were gapping down Monday morning with an open price 31.7% lower than Friday's closing price. The stock closed at $20.20 yesterday and opened today's trading at $13.79.

Theravance Shares Slide on Lung Drug Deaths

Theravance Shares Slide on Lung Drug Deaths

Theravance and partner Glaxo will seek Relovair approvals but data raise safety and efficacy questions.

Theravance Inc. Stock Downgraded (THRX)

Theravance Inc. Stock Downgraded (THRX)

Theravance (Nasdaq:THRX) has been downgraded by TheStreet Ratings from from a hold to sell.

Theravance Inc. Stock Upgraded (THRX)

Theravance Inc. Stock Upgraded (THRX)

Theravance (Nasdaq:THRX) has been upgraded by TheStreet Ratings from a sell to hold.

Insiders Trading THRX, KEG, MKTX

Insiders Trading THRX, KEG, MKTX

The top 10 open-market insider purchases and sales filed at the SEC Wednesday.

Insiders Trading THRX, SLE, LO, PRGO

Insiders Trading THRX, SLE, LO, PRGO

The top 10 open-market insider purchases and sales filed at the SEC Tuesday.

Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call Transcript

Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call Transcript

Theravance Inc. Q3 2010 Earnings Call Transcript

Theravance Inc. Q3 2010 Earnings Call Transcript

4 Stocks Seth Klarman Is Buying in 2010

4 Stocks Seth Klarman Is Buying in 2010

Here's a look at four stocks that Seth Klarman's Baupost Group added to its portfolio in the most recent quarter.

Theravance Inc Q2 2010 Earnings Call Transcript

Theravance Inc Q2 2010 Earnings Call Transcript